Table 3. Cross-validation error rates for discrimination of subgroups of individuals and corresponding resampling p-values.
CD vs. HCs | UC vs. HCs | UC vs. CD | L2 CD vs. L1/L3 CD | UC vs. L1/L3 CD | UC vs. L2 CD | CD Remission vs. HCs | UC Remission vs. HCs | CD Remission vs. UC Remission | |
---|---|---|---|---|---|---|---|---|---|
LOO-CV error rate | 0.12 | 0.19 | 0.41 | 0.29 | 0.28 | 0.35 | 0.14 | 0.22 | 0.32 |
Resampling p-values | <0.025 | <0.025 | 0.1 | 0.175 | 0.85 | 0.075 | <0.025 | <0.025 | 0.025 |
LOO-CV, leave-one-out cross-validation; UC, ulcerative colitis; CD, Crohn’s disease; HCs, healthy controls; L2 CD, colonic Crohn’s disease; L1/L3 CD, ileal/ileocolonic Crohn’s disease; CD remission, Crohn’s disease patients in clinical remission; UC remission; ulcerative colitis patients in clinical remission.